Join
Live feed
·
PRReleasevia Quantisnow
Perspective Therapeutics Inc. logo
Merck & Company Inc. logo

Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors

ByQuantisnow·Wall Street's wire, on your screen.
CATX· Perspective Therapeutics Inc.MRK· Merck & Company Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CATX (Perspective Therapeutics Inc.), MRK (Merck & Company Inc.) and more on Quantisnow.